Background Hypouricaemia is a relatively common disorder in the general population. Since the discovery of the human urate transporter 1 (hURAT1) gene, the number of patients diagnosed with renal hypouricaemia caused by hURAT1 gene mutation(s) has increased. A rapid method for detecting such a mutation(s) for diagnostic aid is described herein.
Introduction
Hypouricaemia, a relatively common disorder in the general population, is de¢ned as serum urate concentrations of less than 119 mmol/L. However cases of idiopathic renal hypouricaemia are rare, with an incidence of 0.15% in Japan, and these cases have been reported mainly among Japanese and non-Ashkenazi Jews. 1 While urolithiasis and exercise-induced acute renal failure are relatively common complications in this disease, 2 most patients are clinically silent. It has recently been reported that these patients have defects in the gene (SLC22A12) encoding the human urate transporter 1 (hURAT1). 3 Interestingly, the allele frequency of the most frequent W258X mutation is calculated to be 2.37%, suggesting that this gene is a major gene for hypouricaemia. 4 Moreover, after the discovery of the gene, the number of patients with mutation(s) in the hURAT1gene has increased and, as a result, a rapid method for detecting such mutation(s) would be highly desirable. Herein, asymptomatic renal hypouricaemia caused by hURAT1 gene mutations and a rapid method for detecting G269A (R90H) mutations are described.
Patient and method
The patient was a 57-year-old Japanese woman. She was an outpatient, su¡ering from left facial nerve palsy, and she had been followed up in our hospital on the suspicion of an acoustic neurinoma. In a recent clinical examination, her height and weight were 157 cm and 55 kg, respectively. Laboratory ¢ndings revealed the following: serum uric acid 41.6 mmol/L, blood urea nitrogen 4.7 mmol/L, creatinine 44.2 mmol/L and urine pH 7. Uric acid clearance (C UA ) and creatinine clearance (C Cr ) ratio: (C UA /C Cr ) was 0.57. Other routine biochemical analyses were normal and she showed no obvious clinical symptoms such as urolithiasis or exerciseinduced acute renal failure.
Gene mutational analysis and screening for the mutation
Judging from the C UA /C Cr ratio, indicating that uric acid excretion was high (normal value o0.10), she appeared to have renal hypouricaemia. Therefore, a hURAT1 gene analysis was performed on the patient and her brother after obtaining written informed r 2007 The Association for Clinical Biochemistry consent, which was approved by the local ethics committee. However, we were not able to obtain DNA from her late father, or from her mother because of an extended illness. Polymerase chain reaction (PCR) ampli¢cation and DNA sequencing of all the exons and exon--intron boundaries for hURAT1 followed essentially the same procedure as previously described. 5 To detect the G269A mutation, we developed a rapid PCR-restriction fragment length polymorphism (PCR-RFLP) analysis. Exon 1 of the gene was ampli¢ed by PCR using the sense primer: R90-S-NotI; 5 0 -AACCAGAGGCCCCATCAGTGCGGCC-3 0 (bold letter G in nucleotide no. 265 from accession No. AB071863 was changed from the authentic C), and the antisense primer: R90-AS; 5 0 -ATAGACCCAGCCATCCA-CACACGGC-3 0 . By inserting G instead of C at the 3 0 region of the R90-S-NotI sense primer, a new NotI digestion site was created in the PCR product. The PCR conditions, using a Perkin Elmer 9700 cycler, were as follows: total of 30 cycles (each cycle 60 s denaturation at 951C, 60 s annealing at 651C and 10 s extension at 721C), and 5 min of ¢nal extension at 721C. The PCR product (size 126 bp) was then digested with NotI. NotI recognizes the normal sequence GCGGCCGC and cuts the normal 126 bp PCR product into two fragments of 102 and 24 bp, respectively. On the other hand, the G to A mutation in G269A changes the recognition site for NotI and, as a result, the PCR product is protected from cleavage. The reaction products were resolved by 4% agarose gel electrophoresis.
Results
As shown in Figure 1 (a) and (b), the DNA-sequence analysis of the patient revealed two mutations in exon 1 and exon 4. The ¢rst mutation was a heterozygous G to A transition at nucleotide 269, which changes R90H: arginine 90 (CGC) to histidine (CAC). The latter was a heterozygous G toA transition at nucleotide 774, which changesW258X: tryptophan 258 (TGG) to a stop codon (TGA). Although we were not able to analyse DNA from the patient's parents, we found, by analysis of the PCR products spanning exon 1 to exon 4 (data not shown), that the two mutations in the hURAT1 gene were located on di¡erent alleles. Consequently, the patient had compound heterozygous hURAT1 gene mutations for renal hypouricaemia.
We initially tested whether the PCR-RFLP analysis functions acceptably for a control, and used a heterozygote and a homozygote for R90H as the positive controls (two patients were applicable to Case 1 and Case 2, respectively, in a report by Ishikawa et al. 2 ). As shown in Figure 1(c) , the PCR-RFLP data were in agreement with each DNA sequence data.We then performed this analysis for the patient and her brother, and found that the patient was, as expected, a heterozygote for R90H and that her brother was also a heterozygote for R90H. Since his uric acid concentration was 23.8 mmol/L, he must have been a compound heterozygote of the hUR-AT1 gene just like the patient. Therefore we also performed PCR screening for W258X, developed by Ichida et al., 6 and found that he was also a heterozygote for W258X (data not shown).
Conclusions
After the discovery of hURAT1, the number of patients discovered to have mutation(s) in this gene has increased. 5 To date, 17 loss-of-function mutations in Fragments were obtained by PCR amplification using exon 1-specific primers as described in Methods section. NotI digestion yields two fragments of 102 and 24 bp from the wild type, whereas it yields three fragments of 102, 24 and 126 bp (undigested product) from a heterozygote, and it yields one fragment of 126 bp (undigested product) from a homozygote. Reaction products were resolved by 4% agarose gel electrophoresis the hURAT1 gene have been identi¢ed in renal hypouricaemia. 2--6 Among these mutations, the most frequent mutation is W258X (approximately 83%), and the second is R90H (approximately 15%). 2--6 Therefore, we developed a rapid method for detecting a G269A (R90H) mutation using PCR-RFLP and we report that it can be a useful diagnostic procedure. Combining the PCR-RFLP analysis for the W258X mutation developed by Ichida et al. 6 with the one developed by us promises to be a more rapid and useful method for screening W258X and/or R90H mutations. In this report, we were clearly able to conclude that the patient was a compound heterozygote for R90H/ W258X and developed a rapid detection method using PCR-RFLP to screen for G269A (R90H) mutations.
